000 | 01815 a2200541 4500 | ||
---|---|---|---|
005 | 20250515093017.0 | ||
264 | 0 | _c20080404 | |
008 | 200804s 0 0 eng d | ||
022 | _a0015-5500 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCai, F | |
245 | 0 | 0 |
_aModulation of the oxidative stress and nuclear factor kappaB activation by theaflavin 3,3'-gallate in the rats exposed to cerebral ischemia-reperfusion. _h[electronic resource] |
260 |
_bFolia biologica _c2007 |
||
300 |
_a164-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiflavonoids _xpharmacology |
650 | 0 | 4 |
_aBrain _xenzymology |
650 | 0 | 4 |
_aBrain Ischemia _xenzymology |
650 | 0 | 4 |
_aCatechin _xpharmacology |
650 | 0 | 4 | _aCell Extracts |
650 | 0 | 4 |
_aCerebral Infarction _xenzymology |
650 | 0 | 4 |
_aCyclooxygenase 2 _xgenetics |
650 | 0 | 4 |
_aGallic Acid _xanalogs & derivatives |
650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
650 | 0 | 4 |
_aGlutathione Peroxidase _xmetabolism |
650 | 0 | 4 |
_aI-kappa B Proteins _xmetabolism |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aNervous System Diseases _xpathology |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xgenetics |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReperfusion Injury _xenzymology |
650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
700 | 1 | _aLi, C | |
700 | 1 | _aWu, J | |
700 | 1 | _aMin, Q | |
700 | 1 | _aOuyang, C | |
700 | 1 | _aZheng, M | |
700 | 1 | _aMa, S | |
700 | 1 | _aYu, W | |
700 | 1 | _aLin, F | |
773 | 0 |
_tFolia biologica _gvol. 53 _gno. 5 _gp. 164-72 |
|
999 |
_c17494614 _d17494614 |